-
About UsBPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
-
S&TInternational-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
-
Research and DevelopmentChina has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
-
BlogIntegrating industry-related media coverage as well as the company’s various activities and updates.
-
Join UsBoasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
-
September 2018
Mr. Bai Xianhong, Chairman of the company, has been honored as a "Prominent Figure in the Pharmaceutical Industry Commemorating 40 Years of Reform and Opening-Up."
September 2018
BIOTECH PHARMACEUTICAL CO., LTD conducts on-site GMP re-certification in Cuba
2017
Cuban National Assembly of People's Power President Lazo visits Bestar to guide the work.
In 2016
Biotech Pharma's project, "Development of Large-Scale Perfusion Culture Technology for Mammalian Cells and Its Industrial Application in Antibody Production," has been awarded the First Prize of the Beijing Science and Technology Award.
September 2015
Cuba's First Vice President of the State Council and First Vice Chairman of the Council of Ministers, Díaz-Canel, visits Baitai.
May 2015
Member of the Political Bureau of the CPC Central Committee and Vice Chairman of the State Council, Salvador Valdés, visits Baitai.
February 2015
Chen Zhu, Vice Chairman of the Standing Committee of the National People's Congress, visits Baitai for inspection.
April 2014
Beijing Mayor Wang Anshun presented the "Great Wall Friendship Award" to Miguel, Director of Production Technology at Baitai.
November 2013
Cuba's Head of Drug Regulation, Pérez Cristia, presented Baitai with Cuba's GMP certificate.
August 2013
Cuba's Minister of Science, Technology, and Environment, Elba Pérez, visits Baitai.
June 2013
Cuba's First Vice President of the State Council and First Vice Chairman of the Council of Ministers, Díaz-Canel, visits Baitai.
May 2013
Beijing Municipal Party Secretary Guo Jinlong visits Baitai for inspection.
April 2013
Chairman Bai Xianhong awarded as one of the "Top 10 Outstanding Individuals" by the Beijing Economic-Technological Development Area
November 2011
In November 2011, Baitai donated 2 million RMB to establish the "China Health Promotion Foundation Targeted Drug Clinical Research Special Fund."
November 2010
Biotech Pharma Named to the "Beijing Biopharmaceutical Industry Leapfrog Development Project (G20 Project) Scale Enterprise List"
July 2010
Construction of Civil Works for Phase II Begins
May 2010
As a representative of achievements in biopharmaceutical development, TaiXinSheng has been selected for display at the Beijing Pavilion during the Shanghai World Expo.
April 2008
Tai Xin Sheng Now Available for Sale
January 2008
Biotech Pharma's monoclonal antibody industrialization facility has obtained China's GMP certification, and in the same year, it also secured Cuba's GMP certification.
November 2007
Biotech Pharma Engineering Research Institute Established
Biotech pharmaceutical co., Ltd
Email: cooperation@biotechplc.com
BD Dept: bd@biotechplc.com
Address：NO.2 Rongjing East Street, Beijing Economic and Technological Development Area, Beijing 100176
Biotech pharmaceutical co., Ltd
E-mail：
Tel：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： BIOTECH PHARMACEUTICAL CO., LTD
表单验证提示文本： Content cannot be empty!
循环体没有内容时： Sorry, no matching items were found.
CSS / JS 文件放置地